Search Results - ping+wu

1 Results Sort By:
PSMA-retargeted adenovirus
C11155: Method of developing targeted therapeutic agents for cancer using adenovirusValue Proposition: • Addresses a major patient need. • Specific for the target. • Enhances adenoviral gene therapy. • Has therapeutic and diagnostic applications. Technical Details: JHU scientists have developed a successful strategy to optimize targeted...
Published: 6/20/2024   |   Inventor(s): Ping Wu, Ronald Rodriguez, Shawn Lupold
Keywords(s): Antigens, Biologics, Cancers, Disease Indication, Drug Delivery Vehicle, Plasmid/Vector, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum